The European Investment Bank (EIB) has signed a loan of up to €35 million with GreenLight Biosciences España to support research and production of ribonucleic acid interference (RNAi)-based biocontrols. RNAi based biocontrols constitute a sustainable alternative to traditional chemical pesticides, with benefits to biodiversity through low or no impact to naturally occurring insect fauna, honeybees, and the soil.